Lysozyme: a major secretory product of a human colon carcinoma cell line.
One of the major proteins secreted by an established human colon adenocarcinoma cell line has been isolated in 25% yield from the serum-free medium in which the cells were grown and identified as lysozyme. Its purification was achieved by sequential steps of acidification, cation-exchange chromatography, and reversed-phase high-performance liquid chromatography. It was recognized to be a human lysozyme on the basis of its molecular weight (14 000), isoelectric point (10.5), amino acid composition, and enzymatic activity. Its identity with previously characterized human lysozymes was established by amino-terminal sequence, peptide composition, immunological properties, NMR, and crystallography. A 4-day, 7-L collection of conditioned medium contained 20.3 mg of secreted protein of which 4.9 mg or approximately 24% of the total was tumor-derived lysozyme. The intracellular level of lysozyme was approximately 18 ng per 10(6) carcinoma cells. The possible significance of these findings in regard to the malignant process and tumor maintenance is discussed.
D000230:Adenocarcinoma / Q000201:enzymology*; D000595:Amino Acid Sequence; D002460:Cell Line; D003110:Colonic Neoplasms / Q000201:enzymology*; D003460:Crystallization; D003470:Culture Media; D006801:Humans; D005779:Immunodiffusion; D008970:Molecular Weight; D009113:Muramidase / Q000302:isolation & purification / Q000378:metabolism*; D010446:Peptide Fragments / Q000032:analysis
D003470:Culture Media; D010446:Peptide Fragments; D009113:Muramidase